# Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty

> **NCT04242407** · PHASE2 · UNKNOWN · sponsor: **Teikoku Pharma USA, Inc.** · enrollment: 164 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** DMTS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04242407
- **Lead sponsor:** Teikoku Pharma USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-07
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04242407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04242407, "Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04242407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*